Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders
NCT07585136Phase 1Recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Nov 2026
- Primary completion
- Dec 2028
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of filgrastim and plerixafor in bone marrow failure syndrome (BMFS), sponsored by St. Jude Children's Research Hospital. Primary endpoint: Incidence of treatment-emergent adverse events at Day 10. Started Nov 2026; status: recruiting.
02
Drugs
filgrastimplerixafor
03
Conditions
bone marrow failure syndrome (BMFS)
Beyond the preview
Go deeper on NCT07585136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07585136.